Literature DB >> 20663850

Adaptive index models for marker-based risk stratification.

Lu Tian1, Robert Tibshirani.   

Abstract

We use the term "index predictor" to denote a score that consists of K binary rules such as "age > 60" or "blood pressure > 120 mm Hg." The index predictor is the sum of these binary scores, yielding a value from 0 to K. Such indices as often used in clinical studies to stratify population risk: They are usually derived from subject area considerations. In this paper, we propose a fast data-driven procedure for automatically constructing such indices for linear, logistic, and Cox regression models. We also extend the procedure to create indices for detecting treatment-marker interactions. The methods are illustrated on a study with protein biomarkers as well as a large microarray gene expression study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663850      PMCID: PMC3006126          DOI: 10.1093/biostatistics/kxq047

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  5 in total

1.  Partitioning and peeling for constructing prognostic groups.

Authors:  Michael LeBlanc; Joth Jacobson; John Crowley
Journal:  Stat Methods Med Res       Date:  2002-06       Impact factor: 3.021

2.  Adaptive risk group refinement.

Authors:  Michael LeBlanc; James Moon; John Crowley
Journal:  Biometrics       Date:  2005-06       Impact factor: 2.571

3.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

4.  Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.

Authors:  Simon Fredriksson; Joe Horecka; Odd Terje Brustugun; Joerg Schlingemann; Albert C Koong; Rob Tibshirani; Ronald W Davis
Journal:  Clin Chem       Date:  2008-01-02       Impact factor: 8.327

5.  Stromal gene signatures in large-B-cell lymphomas.

Authors:  G Lenz; G Wright; S S Dave; W Xiao; J Powell; H Zhao; W Xu; B Tan; N Goldschmidt; J Iqbal; J Vose; M Bast; K Fu; D D Weisenburger; T C Greiner; J O Armitage; A Kyle; L May; R D Gascoyne; J M Connors; G Troen; H Holte; S Kvaloy; D Dierickx; G Verhoef; J Delabie; E B Smeland; P Jares; A Martinez; A Lopez-Guillermo; E Montserrat; E Campo; R M Braziel; T P Miller; L M Rimsza; J R Cook; B Pohlman; J Sweetenham; R R Tubbs; R I Fisher; E Hartmann; A Rosenwald; G Ott; H-K Muller-Hermelink; D Wrench; T A Lister; E S Jaffe; W H Wilson; W C Chan; L M Staudt
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

  5 in total
  16 in total

1.  A Simple Method for Estimating Interactions between a Treatment and a Large Number of Covariates.

Authors:  Lu Tian; Ash A Alizadeh; Andrew J Gentles; Robert Tibshirani
Journal:  J Am Stat Assoc       Date:  2014-10       Impact factor: 5.033

2.  Patient subgroup identification for clinical drug development.

Authors:  Xin Huang; Yan Sun; Paul Trow; Saptarshi Chatterjee; Arunava Chakravartty; Lu Tian; Viswanath Devanarayan
Journal:  Stat Med       Date:  2017-02-01       Impact factor: 2.373

3.  Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.

Authors:  MeiLan K Han; Yueren Zhou; Susan Murray; Nabihah Tayob; Imre Noth; Vibha N Lama; Bethany B Moore; Eric S White; Kevin R Flaherty; Gary B Huffnagle; Fernando J Martinez
Journal:  Lancet Respir Med       Date:  2014-04-21       Impact factor: 30.700

4.  Learning Classification Models of Cognitive Conditions from Subtle Behaviors in the Digital Clock Drawing Test.

Authors:  William Souillard-Mandar; Randall Davis; Cynthia Rudin; Rhoda Au; David J Libon; Rodney Swenson; Catherine C Price; Melissa Lamar; Dana L Penney
Journal:  Mach Learn       Date:  2015-10-20       Impact factor: 2.940

5.  Generated effect modifiers (GEM's) in randomized clinical trials.

Authors:  Eva Petkova; Thaddeus Tarpey; Zhe Su; R Todd Ogden
Journal:  Biostatistics       Date:  2016-07-27       Impact factor: 5.899

6.  Differential distribution improves gene selection stability and has competitive classification performance for patient survival.

Authors:  Dario Strbenac; Graham J Mann; Jean Y H Yang; John T Ormerod
Journal:  Nucleic Acids Res       Date:  2016-05-17       Impact factor: 16.971

Review 7.  Statistical and integrative system-level analysis of DNA methylation data.

Authors:  Andrew E Teschendorff; Caroline L Relton
Journal:  Nat Rev Genet       Date:  2017-11-13       Impact factor: 53.242

8.  Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation.

Authors:  Andrew E Teschendorff; Allison Jones; Heidi Fiegl; Alexandra Sargent; Joanna J Zhuang; Henry C Kitchener; Martin Widschwendter
Journal:  Genome Med       Date:  2012-03-27       Impact factor: 11.117

9.  A PRIM approach to predictive-signature development for patient stratification.

Authors:  Gong Chen; Hua Zhong; Anton Belousov; Viswanath Devanarayan
Journal:  Stat Med       Date:  2014-10-27       Impact factor: 2.373

10.  The cellular growth rate controls overall mRNA turnover, and modulates either transcription or degradation rates of particular gene regulons.

Authors:  José García-Martínez; Lidia Delgado-Ramos; Guillermo Ayala; Vicent Pelechano; Daniel A Medina; Fany Carrasco; Ramón González; Eduardo Andrés-León; Lars Steinmetz; Jonas Warringer; Sebastián Chávez; José E Pérez-Ortín
Journal:  Nucleic Acids Res       Date:  2015-12-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.